Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.9K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

5.5K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

719
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719
Lipid Catabolism01:25

Lipid Catabolism

1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Lipid Digestion01:06

Lipid Digestion

72.9K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
72.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study.

European heart journal·2026
Same author

Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes.

Journal of clinical medicine·2026
Same author

Co-inheritance of ITGA2B and TUBB1 variants in a family reveals distinct genetic contributions to platelet dysfunction.

British journal of haematology·2026
Same author

Unveiling the Genetic Landscape of Inherited Primary Hemostasis Disorders by Whole-Exome Sequencing: Insights from a Multicenter Study.

Thrombosis and haemostasis·2026
Same author

SEA 2026 Standards for Global Control of Vascular Risk.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same author

Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data.

Kidney diseases (Basel, Switzerland)·2026

Related Experiment Video

Updated: Apr 26, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

7.5K

[Familial combined hyperlipidemia: consensus document].

Pedro Mata1, Rodrigo Alonso2, Antonio Ruíz-Garcia3

  • 1Fundación Hipercolesterolemia Familiar, Madrid, España.

Atencion Primaria
|July 19, 2014
PubMed
Summary
This summary is machine-generated.

Familial combined hyperlipidemia (FCH) is a common genetic disorder linked to early heart disease. Early diagnosis and management of FCH, along with other risk factors like diabetes and hypertension, are crucial for patient health.

Keywords:
Cardiovascular diseaseConsensus paperDiabetes mellitus tipo 2Documento de consensoEnfermedad cardiovascularFamilial combined hyperlipidemiaHiperlipidemia familiar combinadaHipertensiónHypertensionLipid-lowering treatmentTratamiento hipolipemianteType 2 diabetes mellitus

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

560
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

7.5K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

560
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.7K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial combined hyperlipidemia (FCH) is a prevalent genetic disorder frequently associated with premature coronary artery disease.
  • It exhibits autosomal dominant inheritance, though a single causative gene has not been identified.
  • Diagnosis relies on clinical criteria including lipid phenotype variability and a family history of hyperlipidemia.

Framework:

  • FCH often co-occurs with type 2 diabetes mellitus, arterial hypertension, and central obesity.
  • Patients with FCH are categorized as high cardiovascular risk.
  • Lipid targets include LDL-cholesterol <100 mg/dL, and <70 mg/dL if cardiovascular disease or type 2 diabetes is present.

Implementation:

  • Lipid-lowering treatment for FCH typically involves potent statins, potentially in combination with other agents.
  • Comprehensive management of co-existing cardiovascular risk factors, such as type 2 diabetes and hypertension, is essential.
  • This guidance offers recommendations for the diagnosis and integrated treatment of FCH.

Implications:

  • Effective management of FCH and associated risk factors can significantly reduce the burden of cardiovascular disease.
  • Specialists and general practitioners can utilize these recommendations for improved patient care.
  • Optimizing treatment strategies for FCH is vital for preventing cardiovascular events.